Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Non-small cell lung cancer

  • You have access
    Impact of Corticosteroids for IrAEs on the Clinical Outcome of Immunotherapy in Patients With NSCLC
    KAZUHIRO SHIMOMURA, TEPPEI YAMAGUCHI, YUKO OYA, KOSAKU UCHIDA and KENTA MUROTANI
    Anticancer Research December 2022, 42 (12) 5961-5969; DOI: https://doi.org/10.21873/anticanres.16106
  • You have access
    Efficacy of Chemoimmunotherapy in NSCLC Patients With Brain Metastasis With or Without Prior Brain Radiotherapy
    YUSUKE TAKAYAMA, JUN YANO, REN SEIKE, SHOHEI MISHIMA and HIROYASU SHODA
    Anticancer Research October 2022, 42 (10) 4805-4812; DOI: https://doi.org/10.21873/anticanres.15985
  • Open Access
    Immunotherapy for Non-small Cell Lung Cancer: Current Agents and Potential Molecular Targets
    NELSON OW SHAM, LEI ZHAO, ZIWEN ZHU, TANNER M. ROY, HUAPING XIAO, QIAN BAI, MARK R. WAKEFIELD and YUJIANG FANG
    Anticancer Research July 2022, 42 (7) 3275-3284; DOI: https://doi.org/10.21873/anticanres.15816
  • Open Access
    Proton Beam Therapy in Elderly Patients With cT1-3N0M0 Non-small Cell Lung Cancer
    MASATOSHI NAKAMURA, HITOSHI ISHIKAWA, KAYOKO OHNISHI, KEIICHIRO BABA, TAKASHI SAITO, TAISUKE SUMIYA, MOTOHIRO MURAKAMI, YUICHI HIROSHIMA, KEI NAKAI, MASASHI MIZUMOTO, TOSHIYUKI OKUMURA and HIDEYUKI SAKURAI
    Anticancer Research June 2022, 42 (6) 2953-2960; DOI: https://doi.org/10.21873/anticanres.15778
  • You have access
    Large Tumor Size and High Neutrophil-to-lymphocyte Ratio Predicts Poor Prognosis After Pneumonectomy or Sleeve Lobectomy in Patients With Non-small-cell Lung Cancer
    TAKUMA TSUKIOKA, NOBUHIRO IZUMI, HIROAKI KOMATSU, HIDETOSHI INOUE, RYUICHI ITO, SATOSHI SUZUKI and NORITOSHI NISHIYAMA
    Anticancer Research June 2022, 42 (6) 3029-3034; DOI: https://doi.org/10.21873/anticanres.15788
  • You have access
    Survival and Early Death Within Three Months from the Start of Immune Checkpoint Inhibitors in Patients With Different Types of Cancer
    CARSTEN NIEDER, SIV GYDA AANES and ELLINOR C. HAUKLAND
    Anticancer Research June 2022, 42 (6) 3061-3066; DOI: https://doi.org/10.21873/anticanres.15793
  • You have access
    Effect of Postoperative Muscle Loss After Resection of Non-small Cell Lung Cancer on Surgical Outcomes
    RYOTA NAKAMURA, SATOSHI YONEYAMA, RIKA TOBITA, SHUSUKE KURIHARA, TAKASHI HATORI, TAKESHI NUMATA, KYOKO OTA, HIDETOSHI YANAI, TAKEO ENDO, YUKINORI INADOME, HIROAKI SATOH and YOSHIHISA INAGE
    Anticancer Research June 2022, 42 (6) 3159-3168; DOI: https://doi.org/10.21873/anticanres.15805
  • You have access
    A Rare Presentation of a Non-Asian Female With Metastatic Non-small-cell Lung Cancer Harboring EGFR L747P Mutation With Clinical Response to Multi-targeted Epigenetic and EGFR Inhibition
    SAMIA S. MESSEHA, MOHAMMAD A. NEZAMI, STEVEN HAGER and KARAM F.A. SOLIMAN
    Anticancer Research January 2022, 42 (1) 441-447; DOI: https://doi.org/10.21873/anticanres.15502
  • You have access
    Pongamol Inhibits Epithelial to Mesenchymal Transition Through Suppression of FAK/Akt-mTOR Signaling
    HARDYANTI EKA PUTRI, BOONCHOO SRITULARAK and PITHI CHANVORACHOTE
    Anticancer Research December 2021, 41 (12) 6147-6154; DOI: https://doi.org/10.21873/anticanres.15434
  • You have access
    CTLA-4 Expression in Tumor-infiltrating Lymphocytes Is Irrelevant to PD-L1 Expression in NSCLC
    SATOSHI MUTO, SHO INOMATA, HIKARU YAMAGUCHI, HAYATO MINE, HIRONORI TAKAGI, YUKI OZAKI, MASAYUKI WATANABE, TAKUYA INOUE, TAKUMI YAMAURA, MITSURO FUKUHARA, NAOYUKI OKABE, YUKI MATSUMURA, TAKEO HASEGAWA, JUN OSUGI, MIKA HOSHINO, MITSUNORI HIGUCHI, YUTAKA SHIO and HIROYUKI SUZUKI
    Anticancer Research December 2021, 41 (12) 6267-6272; DOI: https://doi.org/10.21873/anticanres.15447

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 23
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire